Web monitoring for capturing real-world feedback on drugs
First live demo of PLG’s powerful new AI-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
ProductLife Group (PLG) is to host a webinar on the growing importance of web monitoring as a source of timely, real-world product feedback for drugs companies. The short session, which will take place on 26 April at 2:00PM CET, will include the first live demo of PLG’s powerful new artificial-intelligence-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
During the webinar, AI experts will explore the unique scope of web forums and public social media channels for monitoring consumers’ real-world experience of life sciences products, and to build up an early picture of potential adverse effects. Although the life sciences industry has long understood the potential for timely insight at large scale offered by web and social media listening, the issue until now has been how to monitor these digital channels in an efficient and reliable way to distil the findings that matter - and to do this in a way that respects people’s privacy
.The session will include a first, exclusive look at PLG inVolv via a live demo of the new artificial-intelligence (AI)-based solution, which meets these important criteria. Crucially, it uses machine learning to adapt to the kinds of findings life sciences organisations are most interested in, so that professionals do not waste time looking at content that isn’t of value.
PLG inVolv, which is provided via a software-as-a-service (SaaS) delivery model and is designed to complement rather than replace existing product vigilance and clinical safety systems, is the result of an exclusive partnership with Volv, a specialist in AI-based social listening technology for life sciences.
The webinar, which will run for half an hour, is open to a limited number of participants to allow enough time for a Q&A session following the demonstration. Commenting on the event, Adam Sherlock, CEO of ProductLife Group, said: “Social listening in life sciences, especially in the context of safety and pharmacovigilance, is a hugely hot topic at the moment. Companies are under increasing pressure to proactively track the impact of their products in the market, and what better way than with the help of machine learning and targeted web and social listening? This webinar is very timely, and we expect the session to be over-subscribed.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance